Sewit Teckie

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

William Lee, Sewit Teckie, Thomas Wiesner et al. · Nature Genetics · 2014 · 615 citations · Full text

Malignant Disease, Suz12 Loss, Pathology +6

Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma

Sewit Teckie, Shaohai Qi, Monica Chelius et al. · Annals of Oncology · 2017 · 78 citations · Full text

Long-Term Outcomes and Patterns of Relapse of Early-Stage Extranodal Marginal Zone Lymphoma Treated With Radiation Therapy With Curative Intent

Sewit Teckie, Shunan Qi, Shona Lovie et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 71 citations

Lymphoid Neoplasia, Surgical Oncology, Curative Intent +8

Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone

Sewit Teckie, Joachim Yahalom · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 70 citations

Neuro-oncology, Lymphoid Neoplasia, Ocular Disease +13

High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer

Sewit Teckie, L.M. Scala, Felix Ho et al. · Brachytherapy · 2013 · 29 citations

Neuro-oncology, Surgical Oncology, Radiation Therapy +12